Approval · Notice of Compliance 20141 · 2017
PAYLEAN 20: Notice of Compliance 20141
Issued December 8, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20141
- Date
- December 8, 2017
- Company
- Elanco Canada LimitedGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PAYLEAN 20 | 02268973 | Dormant |
Medicinal ingredients
- RACTOPAMINE HCL 20 G per KG